News | Published:

FDA approves PARP inhibitor for ovarian cancer

Nature Biotechnology volume 35, page 398 (2017) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0517-398

Authors

    Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing